Giubilaro, Jenna http://orcid.org/0000-0003-2746-5134
Schuetz, Doris A. http://orcid.org/0000-0001-8615-9554
Stepniewski, Tomasz M.
Namkung, Yoon http://orcid.org/0000-0002-3085-2066
Khoury, Etienne
Lara-Márquez, Mónica
Campbell, Shirley
Beautrait, Alexandre
Armando, Sylvain
Radresa, Olivier
Duchaine, Jean
Lamarche-Vane, Nathalie http://orcid.org/0000-0002-9540-3157
Claing, Audrey
Selent, Jana
Bouvier, Michel http://orcid.org/0000-0003-1128-0100
Marinier, Anne http://orcid.org/0000-0002-0116-8345
Laporte, Stéphane A. http://orcid.org/0000-0002-0633-543X
Article History
Received: 5 August 2020
Accepted: 17 July 2021
First Online: 3 August 2021
Competing interests
: Some of the BRET-based biosensors used in the present study are licenced to Domain Therapeutics for commercial use. The biosensors are freely available under material transfer agreement for academic research and can be requested from S.A.L. (stephane.laporte@mcgill.ca) or M.B. (michel.bouvier@umontreal.ca). M.B. is the president of the Domain Therapeutics Scientific Advisory Board. All other authors declare no competing interests.